4.4 Letter

No Correlation Between Clinical Response to CTLA-4 Blockade and Presence of NY-ESO-1 Antibody in Patients With Metastatic Melanoma

Journal

JOURNAL OF IMMUNOTHERAPY
Volume 32, Issue 8, Pages 884-885

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CJI.0b013e3181affbf0

Keywords

-

Funding

  1. NATIONAL CANCER INSTITUTE [ZIABC010984, ZICBC010948] Funding Source: NIH RePORTER
  2. Intramural NIH HHS [Z01 BC010984-01] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available